Literature DB >> 16765827

Mutation of gene in spinal muscular atrophy respiratory distress type I.

Virginia C N Wong1, Brian H Y Chung, Susanna Li, Winnie Goh, So Lun Lee.   

Abstract

Spinal muscular atrophy with respiratory distress type I (SMARD1, MIM #604 320) is an uncommon variant of infantile spinal muscular atrophy type I. Distinguishing features include diaphragmatic palsy, early-onset distal limb wasting, and contracture. This report describes a Chinese male with typical features of spinal muscular atrophy with respiratory distress type I. Direct sequencing of the causative gene, the immunoglobulin mu-binding protein 2 (IGHMBP2) gene, revealed the presence of a novel frameshift mutation caused by deletion of G in exon 13 and a single base pair substitution of G to A in exon 12 resulting in substitution of isoleucine for valine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765827     DOI: 10.1016/j.pediatrneurol.2005.10.022

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

1.  Infantile-onset spinal muscular atrophy with respiratory distress-1 diagnosed in a 20-year-old man.

Authors:  Tyler Mark Pierson; Gary Tart; David Adams; Camilo Toro; Gretchen Golas; Cynthia Tifft; William Gahl
Journal:  Neuromuscul Disord       Date:  2011-02-25       Impact factor: 4.296

2.  Selective vulnerability in neuronal populations in nmd/SMARD1 mice.

Authors:  Eric Villalón; Monir Shababi; Rachel Kline; Zachary C Lorson; Kyra M Florea; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

3.  Muscle fiber-type selective propensity to pathology in the nmd mouse model of SMARD1.

Authors:  Eric Villalón; Naomi N Lee; Jose Marquez; Christian L Lorson
Journal:  Biochem Biophys Res Commun       Date:  2019-06-28       Impact factor: 3.575

4.  Validation of the Pathogenic Effect of IGHMBP2 Gene Mutations Based on Yeast S. cerevisiae Model.

Authors:  Weronika Rzepnikowska; Joanna Kaminska; Andrzej Kochański
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.